Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 Inhibitors
about
Profile of palbociclib in the treatment of metastatic breast cancerImpact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancerAcquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib.Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44+/CD24- breast cancer stem cells.
P2860
Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 Inhibitors
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@ast
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@en
type
label
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@ast
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@en
prefLabel
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@ast
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@en
P2860
P356
P1476
Overcoming Endocrine Resistanc ...... ging Role of CDK4/6 Inhibitors
@en
P2093
Ciara C O'Sullivan
P2860
P356
10.23937/2378-3419/2/4/1029
P577
2015-10-14T00:00:00Z